» Articles » PMID: 38151690

Second Primary Cancers Among Females with a First Primary Breast Cancer: a Population-based Study in Northern Portugal

Overview
Specialty Oncology
Date 2023 Dec 27
PMID 38151690
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To estimate the incidence rate of second primary cancers (SPCs) and the cumulative incidence of metachronous [diagnosed > 2 months after a first primary cancer (FPC)] SPCs in patients with a breast FPC, and to compare the incidence of SPC [overall, synchronous (≤ 2 months of the FPC) and metachronous] with that expected in the general female population.

Methods: A cohort of patients with a breast FPC from the North Region Cancer Registry of Portugal, diagnosed in 2000-2010 (n = 15,981), was followed to 31 December 2015 for synchronous and metachronous SPCs. Cumulative incidence of metachronous SPCs considering death as a competing event, and incidence rates and standardized incidence ratios of SPCs were estimated.

Results: The diagnosis of an SPC occurred in 1229 (7.7%) of patients with a breast FPC. SPCs occurred mainly in the breast, followed by digestive organs, lung, thyroid, and female genital organs. Globally, patients with a breast FPC had a higher incidence for all types of cancer compared to the general female population, and in particular for cancers of the breast, stomach, colon, lung, lymphoma, uterus, and ovary. The 10-year cumulative incidence of metachronous SPCs following a breast FPC was 6.6% and the corresponding 10-year cumulative mortality was 26.2%.

Conclusion: In Portugal, patients with a breast FPC have a higher incidence of cancer compared to the general female population, highlighting important aspects of care, surveillance, and counselling among this growing number of patients.

Citing Articles

Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue.

Liang X, Qin Y, Li P, Mo Y, Chen D Ther Adv Med Oncol. 2025; 17:17588359251321904.

PMID: 40012707 PMC: 11863263. DOI: 10.1177/17588359251321904.


Causal effect between breast cancer and ovarian cancer: a two-sample mendelian randomization study.

Qian C, Xing Y, Cheng W BMC Cancer. 2024; 24(1):1433.

PMID: 39573997 PMC: 11580648. DOI: 10.1186/s12885-024-13033-8.


The contribution of second primary cancers to the mortality of patients with a first primary breast cancer.

Goncalves E, Fontes F, Rodrigues J, Calisto R, Bento M, Lunet N Breast Cancer Res Treat. 2024; 207(2):323-330.

PMID: 38869665 PMC: 11297125. DOI: 10.1007/s10549-024-07361-3.

References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Sanchez L, Lana A, Hidalgo A, Rodriguez J, Del Valle M, Cueto A . Risk factors for second primary tumours in breast cancer survivors. Eur J Cancer Prev. 2008; 17(5):406-13. DOI: 10.1097/CEJ.0b013e3282f75ee5. View

3.
Li D, Weng S, Zhong C, Tang X, Zhu N, Cheng Y . Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer. Front Oncol. 2020; 9:1426. PMC: 6970432. DOI: 10.3389/fonc.2019.01426. View

4.
Allen I, Hassan H, Sofianopoulou E, Eccles D, Turnbull C, Tischkowitz M . Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis. Breast Cancer Res. 2023; 25(1):18. PMC: 9912682. DOI: 10.1186/s13058-023-01610-x. View

5.
Parhizgar P, Monfared A, Mohseny M, Keramatinia A, Hashemi Nazari S, Rahman S . Risk of second primary cancer among breast cancer patients: A systematic review and meta-analysis. Front Oncol. 2023; 12:1094136. PMC: 9887162. DOI: 10.3389/fonc.2022.1094136. View